About

Matthew L. Posard has served on the Halozyme Board of Directors since 2013, where he chairs the Nominating and Corporate Governance Committee and serves on the Audit Committee. He brings over 30 years of general management and commercialization experience in the biotechnology and diagnostics industry.

Mr. Posard is Founding Principal of Explore DNA, a life sciences executive consulting firm, a position he has held since March 2016, and since 2017 has provided advisory services to CEOs of several emerging life sciences companies. From February 2017 to April 2018 he served as President and Chief Commercial Officer of GenePeeks, Inc., a genetic research company, and from March 2015 to April 2016 as Chief Commercial Officer of Trovagene, Inc., a molecular diagnostic biotechnology company. From February 2006 to February 2015 he held various commercial and general management positions at Illumina, Inc., including senior executive positions overseeing Global Sales, Marketing, and serving as General Manager of Clinical and Consumer Genomics as well as New and Emerging Markets. He has also held senior positions at Biosite, Inc. and Gen-Probe, Inc.

Mr. Posard holds a B.A. in Management Science from the University of San Diego.

Roles

Halozyme Therapeutics, Inc.
Director · Current role
2013–present
Explore DNA
Founding Principal · Life sciences executive consulting firm.
2016-present
GenePeeks, Inc.
President and Chief Commercial Officer
2017-2018
Trovagene, Inc.
Chief Commercial Officer
2015-2016
Illumina, Inc.
Various commercial and general management positions, including VP Global Sales and SVP/GM of Clinical and Consumer Genomics and New and Emerging Markets · Part of the executive management team that led the company to its first $1 billion in revenue.
2006-2015
Illumina
Commercial and general management positions (Global Sales, Marketing, GM)
2006-2015

External Roles

Nautilus Biotechnology, Inc.
Chairman
Talis Biomedical
Director (recent past public company board)
DermTech, Inc.
Director (recent past public company board)
Nautilus Biotechnology
Chairman
2021-
Stemson Therapeutics
Executive Chairman
2019-

Also at Halozyme Therapeutics, Inc.

Related

See how VectorShift works for your firm

Request Demo